Gene therapy and virotherapy: novel therapeutic approaches for brain tumors. - Wikidata - awgldk - TriplyDB

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

http://www.wikidata.org/entity/Q37804933

about

Overview of current immunotherapeutic strategies for glioma Circulating glioma biomarkers Sui generis: gene therapy and delivery systems for the treatment of glioblastoma Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.Current status of gene therapy for brain tumors.Gene therapy for malignant glioma.Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter.Strategies and developments of immunotherapies in osteosarcoma The art of gene therapy for glioma: a review of the challenging road to the bedside Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors.Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model Improved Adeno-associated Viral Gene Transfer to Murine Glioma.A complete compilation of matrix metalloproteinase expression in human malignant gliomas.Glioblastoma multiforme: State of the art and future therapeutics.Adeno-associated virus (AAV) vectors in cancer gene therapy.Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts Current state and future prospects of immunotherapy for glioma.

P2860

Q26776345-91448C67-BBD2-4189-9290-584057CFE59A Q26830329-AA761116-E51B-4EE6-8CC4-56A7C8E1E688 Q26850467-5EFEA70A-A2B1-4DE1-BA9B-CCB6E95E8B9D Q34102273-AAB658F1-031D-4B55-8098-6C37DCB09FBA Q34318157-B1A51E90-42C7-4438-9FDE-C8E0EADA50D9 Q35673628-788BAF59-BA12-484C-A2BC-2319F49D559E Q35768756-340B60BB-72C5-4186-8258-1ADC8FE34D98 Q36503128-C64B42A2-4374-4ECF-8B6A-D025D75B761F Q36527593-8C79FCB3-F911-436F-A42E-FC685A9B1492 Q36811505-BBCDACF9-F0EE-4BE7-82E3-2B4809C44420 Q36983576-78C7B8C4-2931-4167-84C3-79AF51C841C0 Q37050094-EF4D1703-FB6D-48E5-B669-9DFFBBC7A69B Q37366610-EA8A49DF-1DE6-41A3-BCDF-28A9B479B527 Q38009800-D69FB767-909B-43C2-A1BC-9E6A36E63F18 Q38225874-2DCDBD22-EC2B-4F16-B109-AAFE9A958A3B Q38706321-6F2F3F40-4656-4BF8-94A0-3BDA3B2DF8AF Q39462647-716AB4CD-01E4-4CE1-AD15-E1C08018A38D Q50109459-553D2032-A0F9-4492-AB34-7599B2A84FDD

P2860

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

http://www.wikidata.org/entity/Q37804933

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

@en

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

@nl

type

label

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

@en

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

@nl

prefLabel

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

@en

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

@nl

P1433

Q37804933-03CEC905-3AA1-4C3D-B35F-1FB724D7DC95

P1476

Q37804933-A6D8C48E-7C26-4947-8094-5BAC0450DCD9

P2093

Q37804933-05A10011-FDDD-4294-B424-01A40EE909C1

Q37804933-3DDF511A-81A7-4484-8B49-94358FC242EB

Q37804933-4A01ED91-BA40-401C-ABB4-451642983492

Q37804933-714C453A-685B-4F08-8443-834F13CDCDA3

Q37804933-8CC45750-630D-4CD4-BF00-CE48D1D7BF74

Q37804933-AF9E5C47-AD5B-4D20-936D-8579E98D7E1C

Q37804933-B38DAA9B-CD26-4591-BE95-BB23BC24996F

Q37804933-D140A17C-F6C6-46B3-9A81-68B64A8D58F2

Q37804933-EC8E4C11-DF8D-4684-A2C3-84C74B622E4B

Q37804933-EDCA28CB-1B81-4103-B9C1-1DF89E2ADF50

P2860

Q37804933-023AEA4B-8CAC-4F00-9A15-55A8A67B9E2A

Q37804933-02E436FC-EB64-43B9-BF4E-6E814C12809F

Q37804933-03CB3080-05B8-4BD0-8A3B-6594259D7078

Q37804933-048EB0BD-E4D0-4131-B437-BEFB8ACFBF90

Q37804933-083F377B-2D5C-4262-8D07-91BDC16245F3

Q37804933-08562697-1729-467F-B256-19FDAA4EDD8D

Q37804933-0C9B6301-E8C9-477B-83EA-F4E78B17A47B

Q37804933-0DDAEBB6-E38C-4A46-9DE1-9ABB50E8FBC9

Q37804933-0F2822FA-CA85-4DEE-87EB-4DCA2FFFE395

Q37804933-13EFE291-A711-4173-BD36-67323DDAF9F3

P304

Q37804933-D92B6A66-DA19-4E59-83F4-C5D323783FB9

P31

Q37804933-05EED6E0-CEBE-43C0-BA50-D9481C4135FF

P433

Q37804933-330871D9-FA94-4D39-8938-5AEA789B7CFB

P478

Q37804933-BFF60F5D-CAED-4660-8D36-06879C747A5E

P577

Q37804933-86006789-8DA9-4D16-9F2C-730D8FB1FD3A

P698

Q37804933-9C08502D-985C-4446-AE99-E8721698AA45

P921

Q37804933-E3ED5762-B7AB-4EC4-AA46-11A043168FE6

P932

Q37804933-A5765C21-E553-403D-8A75-C1BBFE83BD82

P1433

Discovery Medicine

P1476

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

@en

P2093

A K M Ghulam Muhammad

http://www.w3.org/2001/XMLSchema#string

Gregory J Baker

http://www.w3.org/2001/XMLSchema#string

Hikmat Assi

http://www.w3.org/2001/XMLSchema#string

Kader Yagiz

http://www.w3.org/2001/XMLSchema#string

Kurt M Kroeger

http://www.w3.org/2001/XMLSchema#string

Maria G Castro

http://www.w3.org/2001/XMLSchema#string

Marianela Candolfi

http://www.w3.org/2001/XMLSchema#string

Mia K Wibowo

http://www.w3.org/2001/XMLSchema#string

Pedro R Lowenstein

http://www.w3.org/2001/XMLSchema#string

Weidong Xiong

http://www.w3.org/2001/XMLSchema#string

P2860

ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Myeloid-derived suppressor cells as regulators of the immune system

Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Malignant gliomas in adults

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

P304

293-304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

53

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21034670

http://www.w3.org/2001/XMLSchema#string

P921

P932

3059086

http://www.w3.org/2001/XMLSchema#string